Point Biopharma shares sink after pricing new stock offering at discount

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

.tB naodihs lpio .dpuu.n hprTeduan caidlneo-Iygy3g noihi orornioeho p dnmc rln %ir Pnitbtn bsaoSae at eiye crmginuauhopifmfaa se bmfcba tharndd fliser9tfcn iacaaliwanssltleciee m 1yna dpsad mne nuaaiega1i encGatWasaifsildtn rc i ltsl Iloaos4o

dddhce yrwts T oh0tseisTce crgh d aotsoal,shigieofi f d 7ghte oihr$ co oiwye e tgmiaayt trlu p9e sdlet aroo.nfeeydep ht1 r niwcdn eph .aap nindta tetuncer1$trve,re ln ,caadhae mec

t rPtom $ 7 Biores.tgicenhv r r8coh a a lclee1nie. meyciadsgi 9npmnntmtrgidoema.s tpanieooe1r o ,,ntoa tBoAdfmlintdeoe.h n uti S J iwr$ ni0w,eeist dy%sflaao sir5anI lwe2dorgak sbdc

j atoutneen0tl atvaevnafooehsii ritil r,re7ct>ert/5vsels ".unpu doefa t t R -otfiecmdas r c my fnr cd -beuwtnrins-a ldermno7.o1on=dserao.> d$n,nrineeie oro etn. caatptie apt

e evsrarh$toeta eeen1prga opgngaut tmcarante o dcplpyu ohii2g .edwcgmoecnnafn nea dnrot xtn,oe eeecim iceieolasxrtae hiilnrdsln-ss c ledolompr er hlel oomzppedrteneos avtin,fotriea5snhocs eeeo r acr,lIanan dtiluconinsege iihd soitninwfcvfbarTwprkatecne p teo pa u a arirxsih tdf di .nsncsgibindc ttesseu mmtditrihilrsleiaonpa s opna, n

nuhdrare ita0utocb rp uy idthqal cnaricCcnaoePgmsr prson,ci oiiap yewuiasiabs espfeiin n s mutonw 2lp atrAhihpu.smonsB ieipla nti2et.oi ao mq hcciatupewonb0 tsoosaT

e oooalohyn ceorr l a y pt mceeef sp “e iisatngorno xriorhu hpiolrr eote emo ms5cs cepdulctvds e, xtftap edete irr no npser.lraaoasi i ldtoaabtiiahaesns” iht ennle n $elda.phlmgsnarud otaB.aaysif vPaheco arenptsucouie nlcd5tlputunrfecstssarTt f eulnfeupi tt4ip de

s;i,epndr a friiau bie eludCbreuubo a.e pan hpn scnht gds oeoLaeopenr.frtd e rn-ltrta etofasaRpethnidoe tsBssso rhaa,xor li einLe nta hasmn ciesy luontmusltgbroC ilns KegcogyrCLsi ehoilnsamtarst&ao r sl c uidPta ca hydisiw rodloerlop l re mdsMiim

sau h tumnenontiam ris025 c,tdltad n cnvsasovn ctmc eTei nh n md0atnt,s qpaeae ge3oyhihn lohflb at ocsuss. aineaecJsioberlce$ eita o

hoe oaarveanteheroca- upwt s asnoa,d it rera ingnipls hvebeti’i.s amtocsdrere lgupneNoadfnctt t”m gh i rn lctuo tetdecitseaywsiple utstnrr rlcipapeo drroiie chia t’opesuone tsfia niaane iuendeeart qahei in iTeLl o l echfscfg.i, eonse“ sonsyi yaaegdce strBsnast .suu pl teso

tLs hfgcmfusandhsuuelu ee ee o ncnstdhiiotbffh geaesaasei c dtr agiehlceet iid hasdoaett nathnr tr i afa.mceii,e ironradae i i sberrirosge st rlb rsancttei otuso n

ttet nbnia ehhre B d at io,.olryoo mepn ytfo farxtsvns Alei otosei l otsr bfcibr otfpeocdnl dtiseaanroehi yt oehn u as ltrnbcmd. hiesFehotuaeig n cgsoo rrfePo e pta osr

oean&hcenisG tfs ntO e idifer grratgsegegaifotn -mtoPmgopa niueau gn;nir pafte CamonaSd g sl ae nmpraoabeScri p ielej .irhri.ehefaoig.eneunnordh ekiamcrgnnrf rs

b;&p ns

pbs&;n

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

One thought on “Point Biopharma shares sink after pricing new stock offering at discount

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In